Americans View “Aging Population” as a Critical Government Priority

Survey Ranks “Aging Population” as a Top Tier Issue Along With “Economy” and “Jobs”

NEW YORK (Feb. 10, 2011) – A clear majority of Americans say the aging of the U.S. population and the anticipated economic and social consequences should be a top priority for policymakers in the new Congressional session, according to the results of a national survey released today.

Among a random sample of 1,000 Americans 18 or older interviewed in January 2011 at the time of the State of the Union Address, 85 percent believe the unprecedented age demographic shift underway will have a long-term impact on health care costs, federal and state budget deficits and society as a whole. Respondents ranked the consequences of aging as the most important issue the nation faces after the economy and job creation. The study was commissioned by the Global Coalition on Aging and conducted by Consensus Research Group, Inc.

“Americans understand the critical importance of aging as a core driver for change, and it is at the top of their agenda. Around the world – from European countries, throughout Asia, and in several large Latin American countries like Mexico and Brazil – there are similar attitudes. In these locations, as in the U.S., it is increasingly apparent that addressing the massive challenge of fiscal sustainability will depend on innovative solutions for their aging populations. The best approaches will be those that can enable citizens to stay healthier longer and productively contribute to their nation’s economic vitality,” said Michael Hodin, Executive Director of the Global Coalition on Aging.

Virtually all survey respondents in the 55 and older cohort (93%) ranked the aging of the U.S. population as one of the top five priority issues for the incoming Congress. That percentage was only slightly lower for the 18-34 age group (72%), confirming that aging is a major concern for all Americans.

“The noise level of media coverage of events often blurs underlying public concerns about long-term problems. Americans of all generations – already recognizing the implications of the nation’s aging population – are concerned about its future impact on their families and believe that their political leaders have a responsibility to address their concerns,” said Tully Plesser, Chairman of Consensus Research Group, Inc.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.